share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  11/13 05:19

Moomoo AI 已提取核心信息

On November 12, 2024, Adial Pharmaceuticals, Inc. conducted its 2024 Annual Meeting of Stockholders, where several key proposals were voted upon. The stockholders approved an amendment to the company's 2017 Equity Incentive Plan, increasing the number of shares authorized for grant from 500,000 to 2,000,000. Additionally, two Class III directors were re-elected to serve a three-year term, and Marcum, LLP was ratified as the company's independent registered public accounting firm for the year ending December 31, 2024. The compensation of named executive officers was approved on an advisory basis, and a three-year frequency for future advisory votes on executive compensation was established. The Board of Directors has decided to adhere to this frequency for holding advisory votes on executive compensation.
On November 12, 2024, Adial Pharmaceuticals, Inc. conducted its 2024 Annual Meeting of Stockholders, where several key proposals were voted upon. The stockholders approved an amendment to the company's 2017 Equity Incentive Plan, increasing the number of shares authorized for grant from 500,000 to 2,000,000. Additionally, two Class III directors were re-elected to serve a three-year term, and Marcum, LLP was ratified as the company's independent registered public accounting firm for the year ending December 31, 2024. The compensation of named executive officers was approved on an advisory basis, and a three-year frequency for future advisory votes on executive compensation was established. The Board of Directors has decided to adhere to this frequency for holding advisory votes on executive compensation.
2024年11月12日,Adial Pharmaceuticals,Inc.进行了其2024年股东大会,股东对几项关键提议进行了表决。股东批准了通过对公司2017年股权激励计划的修正案,将授权发放的股份数量从50万股增加到200万股。此外,公司连任两名III类董事,任期为三年,Marcum,LLP被确认为公司截至2024年12月31日的独立注册会计师。对命名高管的薪酬获得了顾问性通过,并设立了未来三年举行高管薪酬咨询投票的频率。董事会决定遵循此频率举行关于高管薪酬的顾问性投票。
2024年11月12日,Adial Pharmaceuticals,Inc.进行了其2024年股东大会,股东对几项关键提议进行了表决。股东批准了通过对公司2017年股权激励计划的修正案,将授权发放的股份数量从50万股增加到200万股。此外,公司连任两名III类董事,任期为三年,Marcum,LLP被确认为公司截至2024年12月31日的独立注册会计师。对命名高管的薪酬获得了顾问性通过,并设立了未来三年举行高管薪酬咨询投票的频率。董事会决定遵循此频率举行关于高管薪酬的顾问性投票。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息